Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 468

1.

Keel bone fractures induce a depressive-like state in laying hens.

Armstrong EA, Rufener C, Toscano MJ, Eastham JE, Guy JH, Sandilands V, Boswell T, Smulders TV.

Sci Rep. 2020 Feb 20;10(1):3007. doi: 10.1038/s41598-020-59940-1.

2.

Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.

Saylor PJ, Rumble RB, Tagawa S, Eastham JA, Finelli A, Reddy PS, Kungel TM, Nissenberg MG, Michalski JM.

J Clin Oncol. 2020 Jan 28:JCO1903148. doi: 10.1200/JCO.19.03148. [Epub ahead of print]

PMID:
31990618
3.

Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center.

Carlsson S, Benfante N, Alvim R, Sjoberg DD, Vickers A, Reuter VE, Fine SW, Vargas HA, Wiseman M, Mamoor M, Ehdaie B, Laudone V, Scardino P, Eastham J, Touijer K.

J Urol. 2020 Jan 7:101097JU0000000000000742. doi: 10.1097/JU.0000000000000742. [Epub ahead of print]

PMID:
31909690
4.

Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance.

Chesnut GT, Vertosick EA, Benfante N, Sjoberg DD, Fainberg J, Lee T, Eastham J, Laudone V, Scardino P, Touijer K, Vickers A, Ehdaie B.

Eur Urol. 2019 Dec 21. pii: S0302-2838(19)30948-0. doi: 10.1016/j.eururo.2019.12.009. [Epub ahead of print]

PMID:
31874726
5.

Long-Term Outcomes of Active Surveillance for Prostate Cancer - The Memorial Sloan Kettering Cancer Center Experience.

Carlsson S, Benfante N, Alvim R, Sjoberg DD, Vickers A, Reuter VE, Fine SW, Vargas HA, Wiseman M, Mamoor M, Ehdaie B, Laudone V, Scardino P, Eastham J, Touijer K.

J Urol. 2019 Dec 23:101097JU0000000000000713. doi: 10.1097/JU.0000000000000713. [Epub ahead of print]

PMID:
31868556
6.

Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.

Takeda T, Tin AL, Corradi RB, Alvim R, Hashimoto T, Ito Y, Nguyen DP, Mamoor M, Robertson NL, Vargas HA, Benfante NE, Sjoberg DD, Eastham JA, Scardino PT, Fine SW, Oya M, Touijer KA.

Int J Urol. 2020 Feb;27(2):179-185. doi: 10.1111/iju.14161. Epub 2019 Dec 13.

PMID:
31833113
7.

Erectile Function and Sexual Satisfaction: The Importance of Asking About Sexual Desire.

Bravi CA, Tin A, Montorsi F, Mulhall JP, Eastham JA, Vickers AJ.

J Sex Med. 2020 Feb;17(2):349-352. doi: 10.1016/j.jsxm.2019.09.024. Epub 2019 Nov 15.

PMID:
31735617
8.

Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy.

Bravi CA, Tin A, Vertosick E, Mazzone E, Bandini M, Dell'Oglio P, Stabile A, Gandaglia G, Fossati N, Sjoberg D, Touijer K, Cozzarini C, Briganti A, Montorsi F, Eastham J, Vickers A.

Urol Oncol. 2019 Oct 22. pii: S1078-1439(19)30369-2. doi: 10.1016/j.urolonc.2019.09.018. [Epub ahead of print]

PMID:
31653565
9.

Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.

Granlund KL, Tee SS, Vargas HA, Lyashchenko SK, Reznik E, Fine S, Laudone V, Eastham JA, Touijer KA, Reuter VE, Gonen M, Sosa RE, Nicholson D, Guo YW, Chen AP, Tropp J, Robb F, Hricak H, Keshari KR.

Cell Metab. 2020 Jan 7;31(1):105-114.e3. doi: 10.1016/j.cmet.2019.08.024. Epub 2019 Sep 26.

PMID:
31564440
10.

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer.

Lin W, Xu D, Austin CD, Caplazi P, Senger K, Sun Y, Jeet S, Young J, Delarosa D, Suto E, Huang Z, Zhang J, Yan D, Corzo C, Barck K, Rajan S, Looney C, Gandham V, Lesch J, Liang WC, Mai E, Ngu H, Ratti N, Chen Y, Misner D, Lin T, Danilenko D, Katavolos P, Doudemont E, Uppal H, Eastham J, Mak J, de Almeida PE, Bao K, Hadadianpour A, Keir M, Carano RAD, Diehl L, Xu M, Wu Y, Weimer RM, DeVoss J, Lee WP, Balazs M, Walsh K, Alatsis KR, Martin F, Zarrin AA.

Front Immunol. 2019 Sep 4;10:2019. doi: 10.3389/fimmu.2019.02019. eCollection 2019.

11.

Determining conventional and unconventional oil and gas well brines in natural samples I: Anion analysis with ion chromatography.

Cantlay T, Eastham JL, Rutter J, Bain DJ, Dickson BC, Basu P, Stolz JF.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2020;55(1):1-10. doi: 10.1080/10934529.2019.1666560. Epub 2019 Sep 19.

PMID:
31533535
12.

Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy.

Mulhall JP, Kattan MW, Bennett NE, Stasi J, Nascimento B, Eastham J, Guillonneau B, Scardino PT.

J Sex Med. 2019 Nov;16(11):1796-1802. doi: 10.1016/j.jsxm.2019.08.003. Epub 2019 Sep 11.

PMID:
31521569
13.

PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical Prostatectomy.

Haney NM, Faisal FA, Lu J, Guedes LB, Reuter VE, Scher HI, Eastham JA, Marchionni L, Joshu C, Gopalan A, Lotan TL.

J Urol. 2020 Feb;203(2):344-350. doi: 10.1097/JU.0000000000000533. Epub 2019 Sep 10.

PMID:
31502941
14.

Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy.

Bravi CA, Tin A, Benfante N, Salonia A, Briganti A, Montorsi F, Mulhall JP, Eastham JA, Vickers AJ.

Eur Urol Oncol. 2019 Mar 9. pii: S2588-9311(19)30027-6. doi: 10.1016/j.euo.2019.02.003. [Epub ahead of print]

PMID:
31412005
15.

Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Woo S, Suh CH, Eastham JA, Zelefsky MJ, Morris MJ, Abida W, Scher HI, Sidlow R, Becker AS, Wibmer AG, Hricak H, Vargas HA.

Eur Urol Oncol. 2019 Nov;2(6):605-616. doi: 10.1016/j.euo.2019.05.004. Epub 2019 Jun 14. Review.

PMID:
31204311
16.

Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI?

Capogrosso P, Vertosick EA, Benfante NE, Sjoberg DD, Vickers AJ, Eastham JA.

Clin Genitourin Cancer. 2019 Aug;17(4):e745-e750. doi: 10.1016/j.clgc.2019.03.022. Epub 2019 May 16.

PMID:
31201051
17.

Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy.

Recabal P, Lee T, Vertosick E, Manasia M, Eastham J, Touijer K, Seo SK, Spaliviero M, Ehdaie B.

World J Urol. 2019 Jun 12. doi: 10.1007/s00345-019-02845-0. [Epub ahead of print]

PMID:
31190154
18.

In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.

Ito Y, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Fine SW.

Am J Surg Pathol. 2019 Aug;43(8):1061-1065. doi: 10.1097/PAS.0000000000001291.

PMID:
31107718
19.

Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer.

Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE.

J Natl Compr Canc Netw. 2019 May 1;17(5):506-513. doi: 10.6004/jnccn.2019.7306.

PMID:
31085758
20.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
21.

Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy.

Bravi CA, Vertosick E, Benfante N, Tin A, Sjoberg D, Hakimi AA, Touijer K, Montorsi F, Eastham J, Russo P, Vickers A.

Eur Urol. 2019 Sep;76(3):398-403. doi: 10.1016/j.eururo.2019.04.040. Epub 2019 May 10.

PMID:
31080127
22.

Re: Use of Prostate Systematic and Targeted Biopsy on the Basis of Multiparametric MRI in Biopsy-naive Patients (MRI-FIRST): A Prospective, Multicentre, Paired Diagnostic Study.

Carlsson SV, Eastham JA.

Eur Urol. 2019 Oct;76(4):534-535. doi: 10.1016/j.eururo.2019.04.022. Epub 2019 May 4. No abstract available.

PMID:
31064692
23.

Incontinence after Prostate Treatment: AUA/SUFU Guideline.

Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, Kittle C, Lucioni A, Nitti VW, Stoffel JT, Westney OL, Murad MH, McCammon K.

J Urol. 2019 Aug;202(2):369-378. doi: 10.1097/JU.0000000000000314. Epub 2019 Jul 8.

PMID:
31059663
24.

Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy.

Dean LW, Tin AL, Chesnut GT, Assel M, LaDuke E, Fromkin J, Vargas HA, Ehdaie B, Coleman JA, Touijer K, Eastham JA, Laudone VP.

Urology. 2019 Aug;130:120-125. doi: 10.1016/j.urology.2019.04.021. Epub 2019 Apr 26.

PMID:
31034916
25.

Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.

Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA.

Eur Urol Oncol. 2019 Mar;2(2):166-173. doi: 10.1016/j.euo.2018.08.011. Epub 2018 Sep 22.

PMID:
31017093
26.

Reply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today?

Jang TL, Kim IY, Scardino PT, Eastham JA.

Cancer. 2019 Mar 12. doi: 10.1002/cncr.32054. [Epub ahead of print] No abstract available.

PMID:
30861093
27.

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, Sanford BL, Eastham JA, Walther PJ, Morris MJ, Small EJ.

Prostate Cancer Prostatic Dis. 2019 May;22(2):309-316. doi: 10.1038/s41391-018-0106-1. Epub 2018 Nov 1.

28.

Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.

Ito Y, Udo K, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW.

J Urol. 2019 Mar;201(3):535-540. doi: 10.1016/j.juro.2018.09.060.

PMID:
30300632
29.

Innervation of the Epithelium and Lamina Propria of the Urethra of the Female Rat.

Eggermont M, De Wachter S, Eastham J, Gillespie J.

Anat Rec (Hoboken). 2019 Feb;302(2):201-214. doi: 10.1002/ar.23937. Epub 2018 Nov 13.

30.

Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer.

Tosco L, Briganti A, D'amico AV, Eastham J, Eisenberger M, Gleave M, Haustermans K, Logothetis CJ, Saad F, Sweeney C, Taplin ME, Fizazi K.

Eur Urol. 2019 Jan;75(1):44-60. doi: 10.1016/j.eururo.2018.07.027. Epub 2018 Oct 2.

PMID:
30286948
31.

Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.

Jang TL, Patel N, Faiena I, Radadia KD, Moore DF, Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y, Kim IY, Lu-Yao GL.

Cancer. 2018 Oct 15;124(20):4010-4022. doi: 10.1002/cncr.31726. Epub 2018 Sep 25.

32.

Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.

Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP.

Eur Urol. 2019 Feb;75(2):221-228. doi: 10.1016/j.eururo.2018.08.039. Epub 2018 Sep 17.

33.

Evidence for changing nerve growth factor signalling mechanisms during development, maturation and ageing in the rat molar pulp.

Mahdee A, Eastham J, Whitworth JM, Gillespie JI.

Int Endod J. 2019 Feb;52(2):211-222. doi: 10.1111/iej.12997. Epub 2018 Sep 19.

PMID:
30099752
34.

Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.

Dean LW, Assel M, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Ehdaie B, Fine SW.

J Urol. 2019 Jan;201(1):77-82. doi: 10.1016/j.juro.2018.07.062.

35.

Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience.

Murray KS, Spaliviero M, Tonorezos ES, Lacouture ME, Tap WD, Oeffinger KC, Vargas HA, Eastham JA.

Urology. 2018 Sep;119:55-61. doi: 10.1016/j.urology.2018.06.008. Epub 2018 Jun 21.

36.

Outcomes of salvage radical prostatectomy following more than one failed local therapy.

Sivaraman A, Scardino P, Eastham J.

Investig Clin Urol. 2018 May;59(3):152-157. doi: 10.4111/icu.2018.59.3.152. Epub 2018 Mar 20.

37.

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?

Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J.

Investig Clin Urol. 2018 Mar;59(2):83-90. doi: 10.4111/icu.2018.59.2.83. Epub 2018 Feb 22.

38.

Regional Structural and Functional Specializations in the Urethra of the Female Rat: Evidence for Complex Physiological Control Systems.

Eggermont M, de Wachter S, Eastham J, Gillespie J.

Anat Rec (Hoboken). 2018 Feb 16;301(7):1276-1289. doi: 10.1002/ar.23795. [Epub ahead of print]

39.

Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA.

J Urol. 2018 Jun;199(6):1502-1509. doi: 10.1016/j.juro.2017.12.056. Epub 2018 Jan 4.

PMID:
29307681
40.

Evidence for programmed odontoblast process retraction after dentine exposure in the rat incisor.

Mahdee A, Eastham J, Whitworth JM, Gillespie JI.

Arch Oral Biol. 2018 Jan;85:130-141. doi: 10.1016/j.archoralbio.2017.10.001. Epub 2017 Oct 10.

PMID:
29073561
41.

The evolution of chemotherapy for the treatment of prostate cancer.

Quinn DI, Sandler HM, Horvath LG, Goldkorn A, Eastham JA.

Ann Oncol. 2017 Nov 1;28(11):2658-2669. doi: 10.1093/annonc/mdx348. Review.

42.

Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.

Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N, Gandaglia G, Eastham JA, Scardino PT, Vickers A, Cozzarini C, Montorsi F, Briganti A.

Eur Urol. 2018 Jun;73(6):890-896. doi: 10.1016/j.eururo.2017.09.027. Epub 2017 Oct 16.

43.

Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.

Audenet F, Vertosick EA, Fine SW, Sjoberg DD, Vickers AJ, Reuter VE, Eastham JA, Scardino PT, Touijer KA.

J Urol. 2018 Apr;199(4):961-968. doi: 10.1016/j.juro.2017.10.010. Epub 2017 Oct 10.

44.

Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens.

Takeda T, Tin AL, Corradi RB, Mamoor M, Benfante NE, Sjoberg DD, Scardino PT, Eastham JA, Fine SW, Touijer KA.

Eur Urol. 2018 Apr;73(4):488-490. doi: 10.1016/j.eururo.2017.08.005. Epub 2017 Aug 26.

45.

Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.

Beltran H, Wyatt AW, Chedgy EC, Donoghue A, Annala M, Warner EW, Beja K, Sigouros M, Mo F, Fazli L, Collins CC, Eastham J, Morris M, Taplin ME, Sboner A, Halabi S, Gleave ME.

Clin Cancer Res. 2017 Nov 15;23(22):6802-6811. doi: 10.1158/1078-0432.CCR-17-1034. Epub 2017 Aug 25.

46.

An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients.

da Silva V, Cagiannos I, Lavallée LT, Mallick R, Witiuk K, Cnossen S, Eastham JA, Fergusson DA, Morash C, Breau RH.

Can Urol Assoc J. 2017 Aug;11(8):238-243. doi: 10.5489/cuaj.4093.

47.

Prostate cancer screening.

Eastham J.

Investig Clin Urol. 2017 Jul;58(4):217-219. doi: 10.4111/icu.2017.58.4.217. Epub 2017 Jun 20. Review. No abstract available.

48.

Trends and Clinical Practice Patterns of Sacral Neuromodulation for Overactive Bladder.

Elterman DS, Chughtai B, Vertosick E, Thomas D, Eastham J, Sandhu J.

Female Pelvic Med Reconstr Surg. 2018 Jul/Aug;24(4):264-266. doi: 10.1097/SPV.0000000000000449.

PMID:
28658001
49.

Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Gucalp A, Iyengar NM, Zhou XK, Giri DD, Falcone DJ, Wang H, Williams S, Krasne MD, Yaghnam I, Kunzel B, Morris PG, Jones LW, Pollak M, Laudone VP, Hudis CA, Scher HI, Scardino PT, Eastham JA, Dannenberg AJ.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):418-423. doi: 10.1038/pcan.2017.31. Epub 2017 Jun 27.

50.

Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.

Zareba P, Eastham J, Scardino PT, Touijer K.

J Urol. 2017 Nov;198(5):1077-1084. doi: 10.1016/j.juro.2017.06.062. Epub 2017 Jun 15.

Supplemental Content

Loading ...
Support Center